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ABSTRACT 
Serum copper levels were determined in patients with psoriasis. a wide variety of other 
dermatoses, and normal controls by atomic absorptton spect rophotometry. In Series f, 
comprising 73 psoriatics and 66 normal controls of both sexes, serum copper levels were 
elevated in the psoriatics of both sexes but the elevation was not significant statistically. ln 
Series II, using a more sensitive technic. serum copper levels were significantly h igher in 60 
psoriatic men as compared to 73 healthy male controls. Serum copper levels are higher in 
psoriatic a nd normal women as compared to their male counterparts. and tend to rise with 
age in both psoriatics and healthy controls. A screening survey of 79 patients with 38 var-
ious other dermatoses, including 10 patient with contact dermatitis, failed to reveal signifi-
cant abnormalities. 
Lipkin eta/. ( ll. Kekki el a/. (2), and :Vlolokhia 
and Portno~ (:ll reported an increase in total 
serum copper le' els in patients with psoriasis as 
compared to healthy normals. In the study of 
Kekki et al. (:2) the increase tn copper levels was 
attributed to the non-ceruloplasmin bound frac-
tion. Koskela et al. (4) reported normal cerulo-
plasmin serum levels 111 uncomplicated psoriasis. 
but found elevated ceruloplasmin levels in pa-
tients with psoria::.is and roentgenologically con-
firmed arthritis. 
In view of the possible significance of these re-
ports as possibly indicating an abnormality of 
copper metabolism in psoriasis we have reinvesti -
gated this problem. In thili study. total serum 
copper levels of patients with psoriasis but with-
out a rthrit is were compared with those of nor-
mals without skin disease. A survey of serum 
copper levels in a wide ,·ariety of other derma-
toses were also made. 
MATERIALS AND METHODS 
Th1s report mcludes two senes of patients stud1ed for 
serum copper levels. Series I included 73 presumably 
healthy psonatics without arthritis. 66 normal controls 
without skm disease, and 79 patients with various der-
matoses, of both sexes. Serum copper values in erie~ I 
were determined by atomic absorption spectropho-
tometry (AAS) using the method of Piper and Higgins 
(5) by Bio-Sc1ence Laboratories, Van Nuys, California. 
Series II included 60 presumably healthy male pso-
riatics without arthritis and 73 normal males without 
skin disease. Serum copper values in Series ll were also 
This study was supported in part by a grant from the 
,John A. Hartford Foundation 
Received March 13, 1970; accepted for publication 
September 22. 1971. 
• From the tDepartment of Dermatology and the 
tDepartment of Pathology and Clinical Laboratones. 
Stanford University School of Medicine, Stanford, 
California, 94305. · 
t Present addrebS: Department of Dermatology, Uni-
versity of California School of Medicine. San Francisco. 
Calif. 94122. 
28 
determined by AAS, usin~t the method of Olson and 
Hamlin (fi), m the Chmcal Laboratories. Stanford Uni-
versity School of Medicine 
In both Senes blood was drawn from the antecubital 
\('In usmg a d•sposable needle and pla~tic sy nnJ(e. The 
blood was allowed to clot overn1ght 10 a o;iliconi7t'd glass 
tube !Bccton -D1ckmson Vacutainer). In Senes I the 
1.erum was transferred to a plastic vial and mailed to 
Bio-Science Laboratones. In Sene~ II the serum was 
transferred to another glass Vacutainer until analyzed. 
In both Sl'ries the sera was quickly frozen and analyzed 
withm a few weelu; after collection. 
The only difference between the AAS techmques used 
in Series I and Series 11 is that in Series IJ the solution 
of serum. t richloracetic acid. and butanol IS digested m 
a 90° C water bath fur Hi minutes, whereas in Series I 
the solut1on stands at room temperature for 30 minutes. 
We attribute the overall higher copper values in . cries 
II as rom pared to • eries I to a greater release of copper 
from serum protein by digesting at 90• C rather than at 
mom temperature. although other factor<> may have 
been operative. 
Patients with various disease states or condn10ns. or 
on dru~:s known to affect serum copper levels !see Dis-
cussion! were exrludE'd from Series I and ll. Patients on 
methotrexate were al!'O excluded even though we have 
no data on the effect of methotrexate on copper levels. 
Results 10 some m1scellaneous patients are described 
~eparately. 
RESULTS 
Inasmuch as serum copper values are generally 
higher in women than men (7, 8, 9), the sexes were 
compared directly (Table I). In Series I the mean 
serum copper value of 141.6 ~g% in psoriatic 
women was significantly higher than the mean of 
121.1 llg% in psoriatic men (P < .001). imi larly 
the mean serum copper value in normal women of 
129.9 llg% was significantly higher than that of 
111.2 llg% in normal men (P < .001). In Series n 
sera were obta ined only from men . 
Harman ( 10) reported that serum copper values 
rise linearly with age in men. We have therefore 
attempted to determine if there was an age de-
pendent rise in these values in both psoriatics 
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TABLE I 
Serie.~ I. Serum copper values in normals and p.mrrasis. 
- -
St'x ''~• I C'u · ~~· l f'+ p' ormah; M ~an , s .E _J __ nnn~8 ilJin~~t \ll t·an , S.tt: :1:1 24 61 :18.5 ~ 1.9 78 150 111.2 ± 3.0 } Psoriasis M .j.j l!i 87 46.7 l 2.4 R6188 l:ll.O .... 3.0 0.1- 0.2• 
Normals F' 
Psoriasis F 
:3:3 22 60 37.9 I 2.0 85 188 J:l9.9 I 4.J ) # :l9 15 8!i 4:3.:3 I :3.4 94 216 1·11.6 ... 4.8 
number of subjects. 
• P value for si~ificance of difference in copper values between normal and psoriatic men. 
II see text. 
TARLE ll 
Rti.e in copper calue11 u·tlh aRe 
=--~0 ~sio.posE T p' 
' ormals (f) M l 33 0.96 , 0.22 < .001 
Psoriasis (I) M 4 t 0.50 ; 0.18 < .0 I 
Normals (I) F 3:l l. :ll .1. 0.29 .001 
Psoriasis ( () F' :l9 O.Q7 .t. 0.27 < .80 
Normals (lJJ M 73 0.22 I 0.14 <.20 
Psoriasis (I fJ M 60 0.8 1 J 0.20 <. .00 1 
cries I; II Ser•e~ II 
• P value for test of thE' sign ificance of the difference 
of t he slope from zero. 
and normals (Table In. In a ll six groups, male 
and female normals and psoriatics in Series I. 
and male normals and psoriatics in eries ll, 
there was an increase in copper levels with age 
when straight lines were fitted to the data. Four 
of the 6 slopes for the straight lines were signifi-
cantly different from zero at the .01 level or less. 
Although there were differences in slope bet ween 
normals and psoriatics the differences were not 
consistent, and no conclusions have been drawn 
as to whether or not copper levels increase more 
rapidly with age in psoriatics as compared to 
normals. Nevertheless, in view of the tendency of 
serum copper levels to increase with age in both 
psoriatics and normals we believe that it is neces-
sary to correct for age differences in any compara-
tive evaluation. 
In Series I (Table I) serum copper values were 
higher in the psoriatic men (mean 121.0 J.Lg%) as 
compared to the normal men (mean 111.2 J.Lg'11 ). 
The mean age of the psoriatic men (46.7) was 
higher than that of the normal men (38.5). Ad-
justing for age by standard analysis of covariance, 
the significance test P value for the difference in 
means was between 0.1 and 0.2. Similarly the 
mean serum copper value of 141.6 1-1g% in the pso-
riatic women was higher than that of 129.9~-Lg% in 
the normal women. The mean age of the psoriatic 
women (43.3) exceeded that of the normal women 
(37.9). A significance test for the difference in 
copper values in the two groups of women was 
not computed because of the marked difference in 
the slopes for Cu vs. age for the two groups (Table 
m. 
In eries II (Table III) the mean serum copper 
level for the complete series of 73 normal men, 
ages 18 86, was 117.3~-Lg~ as compared to a mean 
value of 154.0 1-Lg''!c for the complete series of 60 
psoriatic men, ages 17 79, the difference being 
highly significant (P < .001). Since the mean age 
of psoriatics (47.9) was higher than that of the 
normals (40.6) several methods were used to cor-
rect for this age difference. Inas much as occult 
pathological conditions a re more apt to occur in 
elder age groups, a comparison was made between 
psoriatics and normals age 60 and younger. By so 
doi ng the difference in mean age was na rrowed, 
40.3 for psoriatics vs. 38.1 for normals. However, 
it can be seen that the difference in copper levels, 
117.8 1-1g% for normals vs. 148.4 1-Lg<;t for psoriatics, 
does not change much and the difference in 
means remains highly significant (P < .001). Fur-
ther, when linea r regression methods were used to 
estimate the mean copper levels for the two 
groups at age 45, the estimated values were 118.2 
.t 2.3 1-1g% for the normals and 151.6 .±. 3.3 1-1g"f 
for the psoriatic group. again a difference that is 
highly statis tically significant (P < .001). 
Serum copper levels were plotted against ex-
tent of body involvement by psoriasis (< 5% to 
lOOOf) in men in Series I and ll. In Series I ( 
-12) serum copper levels rose with increasing ex-
tent of involvement with a slope of0.16 ± 0.14. A 
test of the significance of the difference of the 
slope from zero gave a P value of 0.2 0.3, which is 
not statistically significant. In Series ll ( 60) 
serum copper levels plotted against extent of in-
volvement rose with a somewhat steeper slope of 
0.24 :1. 0.13, but was still not s tatis tically signifi-
cant (P = .05 .10) . 
erum copper levels were determined in 53 
men and 27 women with various dermatoses in 
Series I. In addition, 4 men with atopic derma-
titis were studied using the method for Series II. 
The various dermatoses and the number of pa-
tients (indicated in parentheses) surveyed in Se-
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TAHL.E Ill 
Srrlt'.\ II S1·rum ,·upper L·aluf·,, in normal' and p.mrrnM., lml'n unlyl . 
I-- . ~ 
' 
--- ----1 p H.onr• \1ran , !"'> 1-:. R.tnt r l \tun .. !"f.: ;\;mmal~ IAI l'"<lriasi, I AI 7~ 18· 86 40 fi 1. l.b 68-r;a lli.3 ± ~.2 }F fill li i!l li .!l t: :.!.1 R4 · 229 15UI t 3.7 
:-<ormal~ (Bl 
Psflrt8~1s ( Bl 
~~ 
13 
111 60 
li f,() 
=~. 1 i' l.f, 
411.:1 ± 1.~1 
68 17:1 117.8 '% 2.:1 } <.!lOt I HIM IlK 1 t- ·1.3 
.,L_ ~ 
;-.: number uf suhjPct .... Groups,\ rm• the compll'lt• 6trit•l". Gruups B indudr only thu:;e in J!'roups A that art• BJ!'I! 
f,O nr \·nunll!E'r. 
nes l fo llow· acne (il. acrocyannsi' (II. angiue 
dema (1). atopic dermatitis 111 bttsal cell care~ 
noma !5). Bo"en'., disease (ll , contact dermatitis 
(101. drug eruptum 121. dyshidrn..is 121, erythema 
d;.·~hromicum perst.ans ( 11, t inca corporil' (II, 
eruptive histiocytoma (11. ll'J( ulcers (1), discoid 
lupus erythematosus (6). lymphocytic mfiltratl' 
(.)essner's) ( I ). mali~nant melanoma. metastaw· 
(I), mycosi~ fungoides (4), necrobiosis lipoidica 
(I), nummular ec1.ema (I 1. Pa~tet 's d1,ease. ext ru 
mammar) ( 11. pemphigus foliarenus Ill. photo· 
dermattus (21. photo-contact dermatiti!; (31. pig-
mented ne\ 1 (I I. p1tyrias1;;. rn.~en ( 11, prurllu,., J(en -
eralized (diabetic) Ill. prurilu;;. vulvae ( 1). p,.,eu -
doxanthoma elasllcum (21, !lcleroderma (progrt•R-
Sive, systemic) ( ll. scleroderma (morphea) (I), 
"Cbaceous cyst.." ( 1). seborrheit· dermatitis (21, 
~cborrhetc keratose!.' ( ll. stash. dt-rmatitil' (2). urti · 
caria. chrome {1), \itiligo (poliosi,) ()), warts 121. 
A 52-year-old man w1th metastatit· malignant 
melanoma had an elevated serum t•opper value nf 
155 ~o~g'~. Four men w1th mycosis fungo1des had n 
moderate(\ elevated mean \'alue of 129.:3 Ill!.' 
There was no noticeable trend 1<1r ele\'ation or 
depression of copper \'alues in an~· of the other 
dermatoses suf\·e_ved. Ten patil'nt:-. with contal·t 
dermatttls (6 men and 4 womenl had a mean 
value of I 14 .2 pgr.,, well within the normal ranJ(e 
Thi s mcluded one 49 year old man with an exten 
s1ve exfoliative dermatitis whnse serum coppc>r 
\'alue was only ill pg~ 
Many of the patients in this study were on \'ar-
i•>U!O types of topical therapy at the time of tht• 
takin~t of the blood sample. Twenty-the were em n 
combination of stern1d cream, usuulh 0.1 <;; triam-
cinolone, applied :1 to I times dailv. and 0.1 r; -
0.2~ anthralin with 0.2~ OAr• saltcylic ac1d in 
z1nc paste mn tatntn!( paraffin 22 were e1ther on 
no topical therapy or a bland t•ream; 6 \\ere on a 
.stero1d cream only: 3 on ster••id cream and tar 
ointment: 2 on vanous patent med1cmes: one on 
tar ointment only; and one on top1cal nitro~l'n 
mustard . The mean serum copper \'&lue for the 2!l 
on the anthralin-stl'rold regime was 149.9 ~o~g ": , for 
the 22 on no treatment or bland creams 151.2 
~~~~~- and for the 6 on the steroid creams alone 
159.:J ~tit~ It thus appears that there was no sig-
nificant difference m copper levels in patient,., on 
the an thralin sternad regime as compared to those 
em nn ac tive the rap'> 
To further evaluate the po~sihle inllul'nce of the 
rmthralin-steroid rcgiml' and also the influence uf 
the state ol activity of the P'oriattc process on 
.serum copper len•ls, pre- and post-treatment 
serum copper levels were obtamed m 4 pattl.'nts 
hnllpitalized from H to 14 days. All were treated 
with 0.1 0.2r~ anthralin in 1.inc paste contaming 
paraffin at niJ!ht, and 0.1 ~ tnamcmolone cream 
applied at least four times a da;.·. m !i<>me in-
'tances under pla!'tic occlu!.ion. Crude coal ta r 
ointment was also applied to ~me areas in 2 pa-
tit·ntl> All patient!' showed sll(nif1cant climcal 
amprovement at the end of the huspttalizauon. 
Thl' ~ex, aJ!e, pre and post trl'atml'nt !ierum 
t'opper levels lor the 1 pat1enb follnws. II M 37, 
1-13 ~o~go/r and 130 lllo:lli : lf2 ~ 61. 15fl~tf!ll and 12:1 
I'll~ : ,;3 F 17. 80 ~o~g!)( und 90 1-1g%: 1·1 F 22. 127 
~o~~:"h and 123 ~o~g'iC. It is apparent that the an-
thraltn-stemid re~o:ime did not result in hypercu-
prcmia. 
Serum <·opper \'slue..., <Serie:. I method! were 
nhtained in II women. includinJ( i p,oriatic~ onl' 
nMmal and :1 " ith nther dermatc"e .... who w('re 
either on controt'£'J)l ive pills or estrogens. They 
nre not included in the comt>arallve studies but 
nre presented for Interest. The mean serum 
<'Opper level for thts l{l'OUp Wlls 2:3·1. 2 !. 22.0 j.t J{li. 
"hich is constderubly h1gher than the means for 
the normal and p-onat1c women. This is m 8c· 
cord ''itb the reports of othe~ as tn the marked 
hypl'rcupremic efle<·t ol ~trogens and oral ron-
tmceptives 1 l t. 12, tal . 
OtSCt'SSION 
Approximately 90 95'.'f of serum copper h. 
tighth bound to the alpha 2-globulin. cerulopJa,.,. 
mm. and 5- 10% 1s IOO>.el\' bound to albumin, 
which sef\es 8!. a transport mechanism. A th1rd, 
small fraction of serum copper IS bound to amino 
lll' lds which may have an Important function an 
the transport of copper through membranes ( 14) 
Ceruloplasmin and plasma copper levels are 
under the influence of pituitary-adrenal hor-
mones, and are increased in the rat al ter adre-
nalectomy ( 15) , 
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Inasmuch as women have htgher serum copper 
levels than men (7, 8. 9), segregation by sex is 
necessary in any comparative evaluation. In our 
data serum copper levels were significantly higher 
in both normal and psoriatic women as compared 
to their male counterparts (P <" .001 in both in-
stances). Higher serum copper levels in women 
are most likely due to estrogen. Serum copper 
levels a re elevated in pregnancy after the third 
month (8), and in women taking estrogens (11) or 
oral contraceptive pills (13). The estrogen content 
of contraceptive pills is responsible for their hy-
percupremic effect (12). 
In a series of 569 apparently healthy whtte 
men, ages 20 69, Harman ( 10) found an almost 
linear rise in serum copper levels with age. 
Harman is of the opinion that the rise in serum 
copper values with age has relevance to the free 
radical theory of aging, and may also be a factor 
in the acceleration of atherosclerosis and arterio-
capilla ry fibrosis. Serum copper values also rose 
with age in all of the groups in our study. How-
ever. there was no consistent difference in the 
rate of rise (slope) between the normals and p~o­
riatics. 
erum copper levels are elevated in a variety of 
inf1ammatory, infectious, and neoplastic diseases. 
These include rheumatoid arth ritis (16). rheu 
matic fever ( 17). chronic infections of bacterial or 
viral origin (9. 17. 18). Hodgkin's disease and 
other lymphomas (19). and genital cancer (20). 
Other conditions reported to cause hypcrcu -
premia are thyrotoxicosis, leprosy, systemic lupus 
erythematosus. glomerulonephritis, myocardial 
infarction, metastatic neoplasms, some anemias, 
portal cirrhosis, and major surgery (21) . The cause 
for hypercupremia in such a wide variety of dis-
eases is unknown. While elevated serum copper 
levels and C-reactive proteins are often found 
together there are enough instances of dissocia-
tion to indicate that the two substances are not 
interdependent (22). 
Low serum copper levels are found in hepato-
lenticular degeneration. sprue and celiac disease, 
the nephrotic syndrome and multiple sclerosis 
(21). Corticosteroid adm inistration also has a 
hypocupremic effect (23). 
In the present study serum copper levels were 
higher in psoriatics as compared to healthy nor-
mals. ln Series I. psoriatic men had higher mean 
levels (121.0 1-1g%) than normal men ( 11 L.2 1-1g"f.) 
but the difference was not statistically significant 
(P .lQ-.20). Psoriatic women also had higher 
mean serum copper levels than normal women 
(141.6 1-1g"'r vs. 129.9 1-1g"'r l. however, a test for 8ig-
nificance of difference could not be made because 
of the marked difference in slopes in the rise of 
copper va lues with age between the psoriatic and 
normal women. 
In eries II the elevated serum copper level in 
psoriatic men was highly significant (P < .001). 
Inasmuch as the number of male subjects in Se-
ries II was considerably larger than in Series I. 
and the technique for copper determinations 
more sensitive and performed in our own labora-
tories under uniform condi tions, we attribute 
greater significance to the findings in eries II. 
Our finding of a significant elevation of serum 
copper levels in psoriasis is in accord with that of 
other investigators. However. the number of sub-
jects in our study was considerably larger than 
that in other reports. We have also compared the 
sexes directly and corrected for the rise in serum 
copper values with age. 
While there was a slight tendency for serum 
copper levels to rise with the extent of psoriatic 
surface area this was not statistically significant. 
It would thus appear that the elevated serum 
copper levels in psoria~is a re not simply a reflec-
tion of the extent of involvement 
However. probably a better evaluation of the 
relation of the serum copper levels to disease ac-
tivity would be obtained by a study of serum 
copper levels in the same patient during different 
stages of the disease. This was done by obtaining 
pre- and post-treatment copper levels in four pa-
tients hospitalized for from 8 to 14 days, all of 
whom showed significant clinical improvement. 
There was a moderate decrease in copper levels in 
two, a slight reduction in one, and a mild increase 
in one. However, in the latter patient both the 
pre- and post-treatment values were well below 
the mean. This series of 4 is obviously too small 
to permit a conclusion as to the relation of dis-
ease activity to serum copper value~. 
While no striking abnormalities were found in 
our screening survey of approximately 36 other 
dermatoses the numbers in each group for the 
most part are too small to permit definite conclu-
sions. However, the mean value of 114.2 1-1g% in 
10 cases of contact dermatitis, including a value 
of 70 1-1g 1~ in a case of widespread exfoliative con-
tact dermatitis, would appear to rule out inf1am-
matory dermatitis as such as a cause of hypercu-
premia. Serum copper levels in 2 men and 2 
women in Series I. and 3 men in eries TI with 
atopic dermatitis showed no significant elevation. 
However, inasmuch as atopic dermatitis is com-
parable to psoriasis in having hyperplastic epider-
mis, study of a larger ser ies of atopies is desirable. 
The finding of an elevated value in a patient 
with malignant melanoma is in accord with re-
ports of hypercupremia in metastatic malignan-
cies (21). Four men with mycosis fungoides 
series I) had a mildly elevated mean serum copper 
level. Serum copper levels are significantly ele-
vated in Hodgkin ·s disease and fluctuate with t he 
activity of the process (19). Although serum 
copper levels have been reported as elevated in 
systemic lupus erythematosus (21), there was no 
such trend in our group of 6 patienl<; with discoid 
lupus erythematosus. 
In the four patients hospitalized for treatment 
of psoriasis and receiving frequent applications of 
triamcinolone cream during the day and anthralin 
paste at night it was apparent that this regime 
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did not result in elevated serum copper levels. 
Also there was very little difference in mean 
serum copper levels between those on no topical 
therapy or bland creams as compared to those on 
the most commonly used topical regime of an-
thralin paste alternatinf! with steroid creams. In -
asmuch as the systemic administration of steroads 
tends to lower serum copper levels (23}, the effect 
of topical steroid preparations. if any. would be a 
reduction of those values. 
Whether or not the elevation of serum copper 
levels in psoriasis is in ~orne way related to the 
pathogenesis of the disease can only be specula-
tive at present. Copper has a catalytic oxidizing 
effect on sulfhydryl groups. This has a deleterious 
effect on sulfhydryl dependent enzymes which are 
important in cellular metabolism (24). Copper 
also acts as a catalyst in the formation of disul -
fide cross-linkages from sulfhydryl groups in the 
process of keratinization (25). 
While Lipkin et al. (I) and Molokhia and 
Portnoy {3) found elevated serum copper levels in 
psoriasis, Lipkin et al. (26) found no significant 
differences in the tissue copper levels of psoriatic 
lesions as compared to the uninvolved skin of 
psoriatics and skin of healthy normals. Similarly, 
Molokhia and Portnoy (3) failed to find a signifi-
cant difference in copper levels in the involved or 
uninvolved psoriatic skin as compared to nor-
mals. Inasmuch as the most metabolically active 
fractions of serum copper. Lhe albumin- and 
amino acid-bound fractions (14) constitute a very 
small proportion of total serum copper, normal 
skin concentrations of copper in psoriasis does 
not rule out the possibility of a metabolic abnor-
mality. As Molokhia and Portnoy (3} suggest, fur-
ther studies of trace element metabolism in skin 
diseases are indicated. 
We are indebted to Bvron Brown. Ph.D .. Di-.:1s1on of 
Biostallsllcs. for the statisucal analvs1s; Let1cia Acosta. 
M.S., for techntcal asSIStance and r:exie "\all for prepa-
ration of somf> of the data 
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